The condition is known as familial dysautonomia, which becomes evident during infancy. The hypothesis of this relatively large cadre of regenerative medicine researchers is that genipin from the ...

Tikun Therapeutics Inc. has obtained U.S. orphan drug and rare pediatric disease designations for its programs in familial dysautonomia, namely its rAAV2-U1a-hELP1 gene replacement therapy for the ...

This discovery comes from a group of researchers in the United States studying a rare genetic disease called familial dysautonomia. This condition, which affects the peripheral nervous system ...

Postoperatively, the patient encountered multiple complications, including recurrence of BI, FTT, constipation, dysautonomia, visceral hyperalgesia and neurogenic bladder, necessitating specific ...

Based on our initial experience with this population, we evaluated the presentation rates of 13 diagnoses: CMI, TCS, POTS, MCAD, dysautonomia, myalgic encephalomyelitis/chronic fatigue syndrome ...